These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30630065)

  • 1. Increases in Serum Autoantibodies After Left Ventricular Assist Device Implantation.
    Grosman-Rimon L; Ajrawat P; Lioe J; Tumiati LC; Rao V; Billia F; Chruscinski A
    J Card Fail; 2019 Apr; 25(4):301-306. PubMed ID: 30630065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
    Holzhauser L; Kim G; Sayer G; Uriel N
    Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
    Drakos SG; Kfoury AG; Kotter JR; Reid BB; Clayson SE; Selzman CH; Stehlik J; Fisher PW; Merida M; Eckels DD; Brunisholz K; Horne BD; Stoker S; Li DY; Renlund DG
    J Heart Lung Transplant; 2009 Aug; 28(8):838-42. PubMed ID: 19632582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
    Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
    Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
    Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
    J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality.
    Holley CT; Fitzpatrick M; Roy SS; Alraies MC; Cogswell R; Souslian L; Eckman P; John R
    J Heart Lung Transplant; 2017 Jan; 36(1):91-96. PubMed ID: 27623098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.
    Imamura T; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Chung B; Nguyen A; Ota T; Song T; Juricek C; Jeevanandam V; Burkhoff D; Sayer G; Uriel N
    J Card Fail; 2018 Sep; 24(9):575-582. PubMed ID: 30103020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles.
    Sansone R; Stanske B; Keymel S; Schuler D; Horn P; Saeed D; Boeken U; Westenfeld R; Lichtenberg A; Kelm M; Heiss C
    J Heart Lung Transplant; 2015 Jul; 34(7):921-32. PubMed ID: 25980571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.
    Grosman-Rimon L; Jacobs I; Tumiati LC; McDonald MA; Bar-Ziv SP; Fuks A; Kawajiri H; Lazarte J; Ghashghai A; Shogilev DJ; Cherney DZ; Rao V
    Can J Cardiol; 2015 Mar; 31(3):348-56. PubMed ID: 25746024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation.
    Grupper A; Zhao YM; Sajgalik P; Joyce LD; Park SJ; Pereira NL; Stulak JM; Burnett JC; Edwards BS; Daly RC; Kushwaha SS; Schirger JA
    Am J Cardiol; 2016 Jun; 117(11):1765-70. PubMed ID: 27079215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
    Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95.
    Ankersmit HJ; Edwards NM; Schuster M; John R; Kocher A; Rose EA; Oz M; Itescu S
    Circulation; 1999 Nov; 100(19 Suppl):II211-5. PubMed ID: 10567306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Biventricular Loading Condition in Pediatric LVAD Patient: A Prospective and Observational Study.
    Di Molfetta A; Iacobelli R; Filippelli S; Grutter G; Perri G; Iodice F; Pasquini L; Guccione P; Amodeo A
    Artif Organs; 2018 Apr; 42(4):386-393. PubMed ID: 29230826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.